clenbuterol has been researched along with Hypophosphatemia in 3 studies
Clenbuterol: A substituted phenylaminoethanol that has beta-2 adrenomimetic properties at very low doses. It is used as a bronchodilator in asthma.
clenbuterol : A substituted aniline that is 2,6-dichloroaniline in which the hydrogen at position 4 has been replaced by a 2-(tert-butylamino)-1-hydroxyethyl group.
Hypophosphatemia: A condition of an abnormally low level of PHOSPHATES in the blood.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Clenbuterol is a long acting beta2-adrenergic agonist used in the treatment of pulmonary disorders." | 5.31 | Clenbuterol ingestion causing prolonged tachycardia, hypokalemia, and hypophosphatemia with confirmation by quantitative levels. ( Freyberg, CL; Hoffman, RJ; Hoffman, RS; Nelson, LS; Poppenga, RH, 2001) |
| "Clenbuterol is an oral β2-agonist with anabolic and lipolytic effects that is misused as a performance and image enhancing drug." | 1.56 | Clenbuterol: a new toxic substance in paediatrics. ( Logan, S; McKie, A; Pollock, L; Tester, AA, 2020) |
| "Clenbuterol hydrochloride is a selective beta-2 adrenergic agonist with uses in both humans and animals." | 1.56 | Chomping at the Bit: A Descriptive Report on Pediatric Clenbuterol Ingestion. ( Akpunonu, P; Baum, RA; Mancuso, N; Rutter, PW; Woolum, J, 2020) |
| "Clenbuterol is a long acting beta2-adrenergic agonist used in the treatment of pulmonary disorders." | 1.31 | Clenbuterol ingestion causing prolonged tachycardia, hypokalemia, and hypophosphatemia with confirmation by quantitative levels. ( Freyberg, CL; Hoffman, RJ; Hoffman, RS; Nelson, LS; Poppenga, RH, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Tester, AA | 1 |
| Logan, S | 1 |
| Pollock, L | 1 |
| McKie, A | 1 |
| Woolum, J | 1 |
| Mancuso, N | 1 |
| Rutter, PW | 1 |
| Baum, RA | 1 |
| Akpunonu, P | 1 |
| Hoffman, RJ | 1 |
| Hoffman, RS | 1 |
| Freyberg, CL | 1 |
| Poppenga, RH | 1 |
| Nelson, LS | 1 |
3 other studies available for clenbuterol and Hypophosphatemia
| Article | Year |
|---|---|
Clenbuterol: a new toxic substance in paediatrics.
Topics: Acidosis; Adolescent; Adrenergic beta-Agonists; Chest Pain; Clenbuterol; Diagnosis, Differential; El | 2020 |
Chomping at the Bit: A Descriptive Report on Pediatric Clenbuterol Ingestion.
Topics: Adrenergic beta-Agonists; Child, Preschool; Clenbuterol; Eating; Electrocardiography; Humans; Hypoph | 2020 |
Clenbuterol ingestion causing prolonged tachycardia, hypokalemia, and hypophosphatemia with confirmation by quantitative levels.
Topics: Adrenergic beta-Agonists; Adult; Clenbuterol; Electrocardiography; Enzyme-Linked Immunosorbent Assay | 2001 |